From the HealthyVOICES data:
Edelblute, Heather B. & Jill A. Fisher (2015) Using “Clinical Trial Diaries” to Track Patterns of Participation for Serial Healthy Volunteers in U.S. Phase I Studies. Journal of Empirical Research on Human Research Ethics 10 (1): 65-75.
Monahan, Torin & Jill A. Fisher (2015) “I’m Still a Hustler”: Entrepreneurial Responses to Precarity by Participants in Phase I Clinical Trials. Economy & Society 44 (4): 545-566.
Cottingham, Marci D. & Jill A. Fisher (2016) Risk and Emotion Among Healthy Volunteers in Clinical Trials. Social Psychology Quarterly 79 (3): 222-242.
Cottingham, Marci D. & Jill A. Fisher (2017) From Fantasy to Reality: Managing Biomedical Risk Emotions in and through Fictional Media. Health, Risk, and Society 19 (5-6): 284-300.
Cottingham, Marci D., Julianne M. Kalbaugh, Teresa Swezey, & Jill A. Fisher (2018) Exceptional Risk: Healthy Volunteers’ Perceptions of HIV/AIDS Clinical Trials. Journal of Acquired Immune Deficiency Syndromes 79: S30-S36.
Fisher, Jill A., Lisa McManus, Marci D. Cottingham, Julianne M. Kalbaugh, Megan M. Wood, Torin Monahan, & Rebecca L. Walker (2018) Healthy Volunteers’ Perceptions of Risk in U.S. Phase I Clinical Trials: A Mixed-Methods Study. PLOS Medicine 15 (11): e1002698.
Fisher, Jill A., Lisa McManus, Megan M. Wood, Marci D. Cottingham, Julianne M. Kalbaugh, Torin Monahan, & Rebecca L. Walker (2018) Healthy Volunteers’ Perceptions of the Benefits of their Participation in Phase I Clinical Trials. Journal of Empirical Research on Human Research Ethics 13 (5): 494-510.
McManus, Lisa & Jill A. Fisher (2018) To Report or Not to Report: Exploring Healthy Volunteers’ Rationales for Disclosing Adverse Events in Phase I Drug Trials. AJOB Empirical Bioethics 9 (2): 82-90.
Walker, Rebecca L., Marci D. Cottingham, & Jill A. Fisher (2018) Serial Participation and the Ethics of Phase 1 Healthy Volunteer Research. Journal of Medicine and Philosophy 43 (1): 83-114.
Williams, Quintin & Jill A. Fisher (2018) Captive to the Clinic: Phase I Clinical Trials as Temporal Total Institutions. Sociological Inquiry 88 (4): 724-748.
Fisher, Jill A. (2019) Commentary on Zvonareva et al.: Exploring the Many Meanings of ‘Professional’ in Research Participation. Clinical Trials 16 (6): 571-573.
Fisher, Jill A., Torin Monahan, & Rebecca L. Walker (2019) Picking and Choosing Among Phase I Trials: A Qualitative Examination of How Healthy Volunteers Understand Study Risks. Journal of Bioethical Inquiry 16 (4): 535-549.
McManus, Lisa, Arlene M. Davis, Rebecca L. Forcier, & Jill A. Fisher (2019) Appraising Harm in Phase I Trials: Healthy Volunteers’ Accounts of Adverse Events. Journal of Law, Medicine & Ethics 47 (2): 323-333.
Walker, Rebecca L. & Jill A. Fisher (2019) “My Body Is One of the Best Commodities”: Exploring the Ethics of Commodification in Phase I Healthy Volunteer Clinical Trials. Kennedy Institute of Ethics Journal 29 (4): 305-331.
Jain, Nupur, Marci D. Cottingham, & Jill A. Fisher (2020) Disadvantaged, Outnumbered, and Discouraged: Women’s Experiences as Healthy Volunteers in U.S. Phase I Trials. Critical Public Health 30 (2): 141-152.
Monahan, Torin & Jill A. Fisher (2020) Sacrificial Labour: Social Inequality, Identity Work, and the Damaging Pursuit of Elusive Futures. Work, Employment & Society 34 (3): 441-456.
Cottingham, Marci D. & Jill A. Fisher (online first) Gendered Logics of Biomedical Research: Women in U.S. Phase I Clinical Trials. Social Problems.
Fisher, Jill A., Megan M. Wood, Torin Monahan (online first) Speculating on Precarious Income: Finance Cultures and the Risky Strategies of Healthy Volunteers in Clinical Drug Trials. Journal of Cultural Economy.
Other related publications:
Fisher, Jill A. (2020) Adverse Events: Race, Inequality, and the Testing of New Pharmaceuticals. New York: New York University Press.
Fisher, Jill A. (2007) “Ready-to-Recruit” or “Ready-to-Consent” Populations?: Informed Consent and the Limits of Subject Autonomy. Qualitative Inquiry 13 (6): 875-894.
Fisher, Jill A. (2009) Medical Research for Hire: The Political Economy of Pharmaceutical Clinical Trials. New Brunswick, NJ: Rutgers University Press.
Fisher, Jill A. & Corey A. Kalbaugh. (2011) Challenging Assumptions About Minority Participation in U.S. Clinical Research. American Journal of Public Health 101 (12): 2217-2222.
Fisher, Jill A. (2013) Expanding the Frame of ‘Voluntariness’ in Informed Consent: Structural Coercion and the Power of Social and Economic Context. Kennedy Institute of Ethics Journal 23 (4): 355-379.
Fisher, Jill A. (2015) Stopped Hearts, Amputated Toes, and NASA: Contemporary Legends among Healthy Volunteers in US Phase I Clinical Trials. Sociology of Health and Illness 37 (1): 127-142.
Fisher, Jill A. (2015) Feeding and Bleeding: The Institutional Banalization of Risk to Healthy Volunteers in Phase I Pharmaceutical Clinical Trials. Science, Technology, & Human Values 40 (2): 199-226.
Fisher, Jill A. & Marci D. Cottingham (2017) This Isn’t Going to End Well: Fictional Representations of Medical Research in Television and Film. Public Understanding of Science 26 (5): 564-578.
Fisher, Jill A. & Rebecca L. Walker (2019) Advancing Ethics and Policy for Healthy-Volunteer Research through a Model-Organism Framework. Ethics & Human Research 41 (1): 4-14.
Fisher, Jill A. (2019) Research Payment and Its Social Justice Concerns. American Journal of Bioethics 19 (9): 35-36.